TIM-3, a promising target for cancer immunotherapy

Patients with malignant tumor treated with immunotherapy have received significant clinical benefits over the years. Immune checkpoint blocking agents, such as anti-cytotoxic T-lymphocyte-associated protein-4 (anti-CTLA-4) and anti-programmed cell death protein-1 (anti-PD-1) monoclonal antibodies, h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: He, Yayi, Cao, Jie, Zhao, Chao, Li, Xuefei, Zhou, Caicun, Hirsch, Fred R
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6198883/
https://ncbi.nlm.nih.gov/pubmed/30410357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S170385
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker